Literature DB >> 35183609

Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms.

Giuseppe Lippi1, Riccardo Nocini2, Brandon M Henry3.   

Abstract

Entities:  

Keywords:  COVID-19; Omicron; SARS-CoV-2; Symptoms; Variants

Mesh:

Year:  2022        PMID: 35183609      PMCID: PMC8851877          DOI: 10.1016/j.jinf.2022.02.011

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   38.637


× No keyword cloud information.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic outbreak, is undergoing a progressive evolution characterized by accumulation of several non-synonymous mutations in its genome, garnered for better adaptation to its human host. The most recently emerged SARS-CoV-2 variant called Omicron (B.1.1.529) is raising considerable concern due to the presence of a large number of mutations (more than 30) in the spike protein, which may have substantial impact on infectivity, virulence and pathogenicity of the virus. Preliminary evidence suggests that the new Omicron variant may cause different symptoms and trigger outbreaks associated with less severe illness compared to outbreaks with previous strains, with predominance of milder clinical manifestations such as rhinorrhoea, sneezing, sore throat, headache and fatigue. To provide further insights on this matter, we conducted an electronic search in Google Trends (Google Inc. Mountain View, CA, US), using the most frequent COVID-19 symptoms as search terms (listed in Fig. 1 – translated in Italian). We used country option set to “Italy” and the search periods ranged between January 3 and 9, 2022 (predominance of Omicron variant) and January 2–8, 2021 (predominance of Alpha variant). The weekly Google Trends score of each symptom, reflecting relative popularity of the search term during a specified time range (i.e., number of searches received by Google), was downloaded into a Microsoft Excel file (Microsoft, Redmond, WA, United States) and graphically plotted as percent variation in 2022 compared to the same period in 2021. The study was conducted in accordance with the Declaration of Helsinki, under the terms of relevant local legislation. This analysis was based on electronic searches in the unrestricted, publicly available national repositories, and thus no informed consent or Ethical Committee approvals were required.
Fig. 1

Percent variation of Google searches in the UK between 20 and 26 December 2020 (predominance of Alpha variant) and 19–25 December 2021 (Omicron prevalence >80%).

Percent variation of Google searches in the UK between 20 and 26 December 2020 (predominance of Alpha variant) and 19–25 December 2021 (Omicron prevalence >80%). The results of our analysis are shown in Fig. 1. Most symptoms increased in 2022 compared to 2022, though six (i.e., sneezing, cough, sore throat, fever, chills and headache) displayed >50% increase whilst five (i.e., ageusia, aches, shortness of breath, runny nose and anosmia) were found to be less searched in 2022 compared to the same period in 2021. The results of this early infodemic analysis suggest that the diffusion of highly mutated SARS-CoV-2 variants may be associated with a progressive evolution of the clinical picture. Specifically, the actual predominance of the Omicron (B.1.1.529) variant in the Italy (>80% cases) was associated with a remarkably higher number of Google searches for upper respiratory symptoms mirroring those of common cold and flu, accompanied by a considerable lower interest for shortness of breath (over 20% reduction). Since dyspnoea is a paradigmatic sign of lower pulmonary tract infection (e.g., SARS-CoV-2 pneumonia), this infodemic evidence supports preliminary claims that the Omicron variant outbreak (due to either alterations in intrinsic viral pathogenicity and/or enhanced general population immunity) may be associated with less severe illness compared to outbreaks with previous strains.

Declaration of Competing Interest

The authors have no relevant competing interest to disclose in relation to this work.
  5 in total

1.  Detection of SARS-CoV-2 Omicron (B.1.1.529) variant has created panic among the people across the world: What should we do right now?

Authors:  Md Rabiul Islam; Md Jamal Hossain
Journal:  J Med Virol       Date:  2021-12-30       Impact factor: 2.327

2.  Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show.

Authors:  Gareth Iacobucci
Journal:  BMJ       Date:  2021-12-16

3.  Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2021-12-24

Review 4.  Updated picture of SARS-CoV-2 variants and mutations.

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Brandon M Henry
Journal:  Diagnosis (Berl)       Date:  2021-12-23

5.  Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?

Authors:  Camilla Mattiuzzi; Brandon M Henry; Giuseppe Lippi
Journal:  J Infect       Date:  2021-07-15       Impact factor: 6.072

  5 in total
  7 in total

1.  SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.

Authors:  Jessica Taytard; Blandine Prevost; Aurélie Schnuriger; Guillaume Aubertin; Laura Berdah; Lauren Bitton; Audrey Dupond-Athenor; Guillaume Thouvenin; Nadia Nathan; Harriet Corvol
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

2.  Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis.

Authors:  Lei Huang
Journal:  J Infect       Date:  2022-07-16       Impact factor: 38.637

3.  SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.

Authors:  Gian Luca Salvagno; Brandon M Henry; Laura Pighi; Simone De Nitto; Martina Montagnana; Giuseppe Lippi
Journal:  J Infect       Date:  2022-02-26       Impact factor: 38.637

4.  Estimating the worldwide burden of COVID-19-related anosmia and ageusia.

Authors:  Riccardo Nocini; Camilla Mattiuzzi; Giuseppe Lippi
Journal:  Oral Dis       Date:  2022-07-24       Impact factor: 4.068

5.  Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions.

Authors:  Frederic Jungbauer; Catharina Gerhards; Margot Thiaucourt; Michael Behnes; Nicole Rotter; Angela Schell; Verena Haselmann; Michael Neumaier; Maximilian Kittel
Journal:  Life (Basel)       Date:  2022-06-28

6.  Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19.

Authors:  Tommaso Francesco Aiello; Pedro Puerta-Alcalde; Mariana Chumbita; Patricia Monzó; Carlos Lopera; Juan Carlos Hurtado; Fernanda Meira; Mar Mosquera; Marta Santos; Mariana Fernandez-Pittol; Josep Mensa; José Antonio Martínez; Alex Soriano; Ma Angeles Marcos; Carolina Garcia-Vidal
Journal:  J Infect       Date:  2022-08-06       Impact factor: 38.637

7.  Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant.

Authors:  César Fernández-de-Las-Peñas; Ignacio Cancela-Cilleruelo; Jorge Rodríguez-Jiménez; Victor Gómez-Mayordomo; Oscar J Pellicer-Valero; José D Martín-Guerrero; Valentín Hernández-Barrera; Lars Arendt-Nielsen; Juan Torres-Macho
Journal:  Pathogens       Date:  2022-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.